Day 3 - Spasticity & Neuro Rehab Flashcards

(35 cards)

1
Q

Treatment of Central Pain Post Stroke πŸ”‘

A

First Line

  1. Amitriptyline (75mg/d)
  2. Gabapentin (Neurontin) 900mg/d

Others

  1. Pregabalin (Lyrica) 150mg/d
  2. Naloxone (8mg)
  3. I.V. Lidocaine β†’ short-term (45 min) pain relief only
  4. Morphine infusion (9-30mg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathophysiology of Thalamic/Central Pain States Post Stroke (CPSP)

A

Damage to spino-thalamic pathway β†’ impaired temperature (hot, cold) and pain (pinprick)

β†’ hyperalgesia +/or allodynia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for Post-Stroke Fatigue (PSF)

A
  • Depression
  • Chronic pain
  • Sleep disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Treatment of Post-Stroke Fatigue (PSF)

A
  • Modafinil 200mg/d
  • Cognitive Therapy/Graded Activity Training
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List 2 screening tools for depression πŸ”‘

A
  1. Patient Health Questionnaire (PHQ)-9
  2. Hospital Anxiety and Depression Scale (HADS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List 4 Risk Factors for Depression post stroke

A
  • Female sex (especially those with severe depression)
  • Previous history of depression
  • Stroke severity, functional limitations or need for assistance with activities of daily living
  • Cognitive impairment
  • Social factors (living alone, divorced or living in a nursing home)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List 2 Pharmacological & 2 Non-Pharmacological Management for Depression Post-Stroke

A

Non-Pharmacological Management

  1. Exercise
  2. Cognitive-Behavioural Therapy (CBT)

Pharmacological

  1. TCA β†’ Amitriptyline 10-25mg
  2. SSRI β†’ Escitalopram (Cipralex) 5mg Fluoxetine (Prozac) 10mg
  3. CNS Stiumlant β†’ Methylphenidate (Ritalin) 5mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain brain lobes and their clinical relation.

A

Frontal lobe

  • Laterally separated from the temporal lobes by the Sylvian fissure.
  • Primary motor cortex β†’ voluntary movement β†’ Weakness
  • Problem solving, thinking and planning β†’ Apraxia
  • Behavior & personality

Parietal lobe

  • Primary somatosensory cortex β†’ Perception β†’ Neglect

Temporal

  • Primary auditory cortex β†’ Language β†’ Aphasia
  • Memory, Object and face recognition

Occipital

  • Primary visual cortex β†’ Vision and orientation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List 5 descending tracts.

A
  1. Corticospinal
  2. Vestibulospinal
  3. Rubrospial
  4. Olivospinal
  5. Reticulospinal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mini-Mental State Examination (MMSE) ORAL.C.

A

Orientation

  • D/M/Y, Season and Time
  • Location From country to Ward

Registration

  • 3 Objects

Attentions

  • 100 minus 7 five times

Language

  • Name 2 object
  • Give 3 order command
  • Read command
  • Write sentence

Copy

  • Pentagon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Main challenges in bladder for stroke patient.

A
  1. Incontinence β†’ areflexia
  2. Aphasia β†’ communication
  3. Impaired mobility β†’ WC
  4. Neurogenic Bladder β†’ neurodynamic study
  5. Repeated UTI

Cuccurollo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you manage bladder dysfunction in stroke patient?

A

Failure to store

Antimuscarinic agents

  • MOA: Prevent acetylcholine release from parasympathetic nerves by binding to receptors on the detrusor muscle, thus assisting in bladder storage.
  • Drugs: Solifenacin (Vesicare) or Oxybutynin (Ditropan)
  • Side effects: dry mouth, blurry vision, and constipation

Failure to pass

Adrenergic antagonists

MOA: Inhibit smooth muscle activity in the prostate and at the bladder neck

Side effects: Postural hypotension, abnormal ejaculation, and nasal congestion

Spastic Bladder (Hyperactive)

Baclofen, tizanidine, diazepam, and dantrolene sodium

Botulinum toxin type A

Underactive Bladder

Intermittent catheterization (IC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List 2 investigation you would like to do before treating bladder dysfunction?

A
  1. Urodynamics evaluation
  2. Post void residuals (PVRs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List 2 pharmacological and 2 nonpharmacological treatments for stress incontinence.

A

Pharmacological

  1. Adrenergic agonists
  2. Oxybutynin (Ditropan)

NonPharmacological

  1. Take fiber to avoid constipation
  2. Avoid jumping or running
  3. Pelvic floor muscle exercises
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stroke patient with diarrhea, how do you manage?

A
  1. Treat underlying causes (e.g., bowel infection, diarrhea)
  2. Timed toileting schedule
  3. Training in toilet transfer
  4. Communication skills
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stroke patient with constipation, how do you manage?

A
  1. Adequate fluid intake/hydration
  2. Diet modification (e.g., increase dietary fiber),
  3. Bowel management (stool softeners, stool stimulants, suppositories 3-2-1 program)
17
Q

Decreased sexual activity post-stroke attributed to:

A
  • Inability to discuss sexuality with spouse
  • Unwillingness to participate in sexual activity
  • Reduced body image and self-esteem
  • Positioning problems due to disability and spasticity or muscle weakness
18
Q

Treatment of sexual dysfunction post-stroke

A
  1. Emotional support
  2. Psychotherapy
  3. Medical consultation (urology)
  4. PDE5 inhibitor
  5. Treat underlying spasticity/weakness/contracture
19
Q

Define Spasticity & Modified Ashworth Scale

A

A motor disorder characterized by an abnormal, velocity-dependent increase in the tonic stretch reflexes (muscle tone) with exaggerated phasic stretch reflexes (tendon jerks, clonus) resulting from hyperexcitability of the stretch reflex. It is a component of the UMNS.

Modified Ashworth Scale:

0 No increase in tone

1 Slight increase in muscle tone, manifested by a catch and release or minimal resistance at the end of the ROM when the affected part(s) is moved in flexion and extension

1+ Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the ROM

2 More marked increase in muscle tone through most of the ROM, but affected part(s) easily moved

3 Considerable increase in muscle tone, passive movement difficult

4 Affected part(s) rigid in flexion or extension

20
Q

List 5 management options for spasticity.

A

Prevention first (non-pharmacological)

  • Remove factors or noxious stimuli that may increase spasticity (UTI, etc).
  • Exercises: positioning, stretching/ROM.
  • Bracing: splinting (static vs dynamic), Serial casting.
  • Modalities: cold, electrical stim, FES

Treating second (pharmacological)

  • oral medications β†’ Baclofen
  • focal treatments β†’ BotoX
  • intrathecal baclofen.
  • surgical options (selective dorsal rhizotomy)..

Ref: http://www.abiebr.com/set/case-study-2/27-spasticity-post-abi

21
Q

What is the mechanism of botulinum toxin? 1 Mark

A

Inhibition of acetylcholine release at the neuromuscular junction

22
Q

What is the mechanism of botulinum toxin? 1 Mark

A

Inhibition of acetylcholine release at the neuromuscular junction

23
Q

Postural abnormalities in upper limb and where to inject.

24
Q

Postural abnormalities in wrist and where to inject.

25
Postural abnormalities in hip & knee and where to inject.
26
Postural abnormalities in ankle and where to inject.
27
How much Botox will you inject per muscle and per session? What is the effectiveness timeline of Botox?
* Usual dosage of onabotulinumtoxinA (Botox) is 25 to 200 units per muscle * Initial safe dose for first treatment is likely 400 units total or 6 units per kg for an adult. * Reinjections should occur after 3 months β€œ3 days for initial effect, 3 weeks for peak effect, and 3 months duration.” Cuccurollo
28
List 4 side effects of Botox.
1. Pain/soreness 2. Nerve trauma 3. Hematoma/bruising/local erythema or swelling 4. Flu-like syndrome with headache, nausea, fatigue, general malaise 5. Dysphagia may occur from cervical injection (short-lived) 6. Unwanted weakness in injected or adjacent muscles (localized)
29
List 6 side effects of baclofen.
1. Brain : Depression - Confusion - Headache - Hallucinations 2. Cerebellum : Coordination disorder - Tremor - Ataxia - Nystagmus 3. Basal Ganglia : Dystonia 4. Brainstem : Blurred vision - Slurred speech - Tinnitus - Diplopia - Dysarthria 5. Cardiorespiratory : Hypotension - Dyspnea - Palpitation - Chest pain - Syncope. 6. Gastrointestinal : Nausea - Constipation 7. Genitourinary: Urinary retention - Inability to ejaculate
30
List 4 signs of abrupt drug withdrawal of baclofen
1. Increased spasticity. 2. Agitation 3. Confusion 4. Hallucinations 5. Seizures 6. Psychosis 7. Dyskinesia
31
List 10 surgical operations for treatment of spasticity.
Tendon: Release, Transfer, Lengthening Muscle: Myotomy Nerve: Peripheral neurectomy β†’ Cordectomy β†’ Dorsal Rhizotomy β†’ Myelotomy Devices: ITB Pump, Deep brain stimulator
32
List 4 positive effect of spasticity.
* Hemp in ambulation, standing, or transfers (e.g., stand pivot transfers) * Maintaining muscle bulk due to muscular contraction * Preventing deep vein thrombosis (DVT) by providing improved venous flow secondary to muscle contractions * Preventing osteoporosis * Can serve as a β€œdiagnostic tool” (spasticity can be a sign of exposure to a noxious stimuli : infection, bowel impaction, urinary retention, etc.) Cuccurollo
33
List 4 negative effect of spasticity.
* Interferes with function * Can cause extreme discomfort/pain * Interferes with hygiene and nursing care * Contractures and disfigurement * Increased risk for development of decubitus ulcers * Bone fractures * Joint subluxation/dislocation * Increased risk of heterotopic ossification (HO) * Acquired peripheral/entrapment neuropathy Cuccurollo
34
List 4 triggers of spasticity.
35
List 4 reasons for poor outcome of Botox.
1. Inactive medication 2. Incorrect dose 3. Incorrect diagnosis 4. Incorrect muscle selection 5. Unrealistic goals 6. Disease condition